Acasti Pharma Inc.

NASDAQ:ACST

3.37 (USD) • At close October 25, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q12008 Q3
Revenue 00000-0.03200000000.1150.081000000000000000.0010.0030.0020.0150.0040.0050.0040.1360.0250.0070.0520.1670.0270.2520.0060.0280.4270.2390.0130.01500.0340.0850.02900000000
Cost of Revenue 0.0010.0013.0432.0924.45414.0834.2455.1084.7312.02203.56700.040.0369.61800000000000000000.0550.0020.0020.0020.1410.020.0040.0240.1030.0150.1440.0020.0250.2420.1250.0040.005000000000000
Gross Profit -0.001-0.001-3.043-2.092-4.454-14.115-4.245-5.108-4.73-12.0220-3.56700.0750.045-9.61800000000000000.0010.0030.002-0.040.0020.0040.002-0.0050.0050.0030.0280.0640.0120.1090.0040.0020.1850.1140.0090.0100.0340.0850.02900000000
Gross Profit Ratio 00000441.09400000000.6520.55600000000000000111-2.6610.5290.6670.485-0.040.1950.4020.5360.3830.4310.4310.7020.0830.4320.4790.6660.655011100000000
Reseach & Development Expenses 2.7081.6851.4430.461.0951.642.453.2922.592.3262.1790.5850.4691.3690.6781.2861.7561.7863.883.9636.2618.4927.0167.0656.7574.4863.4082.71.5241.2541.2211.8372.5561.0560.8431.0831.0471.5271.6581.1230.4871.2051.4470.7550.8340.7760.7660.5490.51.3280.9320.4720.6150.3120.2810.2340.2690.2790.3520.2020.091
General & Administrative Expenses 2.2541.4821.571.5891.8112.4651.7031.8252.0841.8221.8082.9572.6761.4431.1051.3191.6491.3581.4831.7961.1321.6690.8471.0140.7880.9570.6880.8350.6280.6170.6540.434-1.0390.9160.7921.0180.6561.0661.5221.6421.231.9281.7531.168000000000.2910.2740.1790000.09700
Selling & Marketing Expenses -0.0010.0610.03-0.0430.060.0510.0720.0030.010.2550.2380.02500.0660.2260.1340.7160.5170.6510.7720.7110000000000000000000000000000000000000000
SG&A 2.2541.5771.61.5461.8712.5161.7751.8282.0942.0772.0462.9822.6761.5091.3311.4532.3651.8752.1342.5681.8431.6690.8471.0140.7880.9570.6880.8350.6280.6170.6540.434-1.0390.9160.7921.0180.6561.0661.5221.6421.231.9281.7531.1680.9661.0461.1021.0311.2590.8150.8640.6560.2910.2740.1790.1020.1470.0980.0970.0610.097
Other Expenses -2.25400000.0090.02-0.01200000-0.91600.0050-00000000-0000-00-00-00000000-00-0000-000000.1390.001-0.00200.02-0.0030.016-0.0210
Operating Expenses 4.9623.2623.0432.0062.9694.1654.2455.1084.734.4034.2253.5673.1451.9622.0092.7444.1213.6616.0136.538.10410.167.8638.0797.5455.4434.0953.5352.1521.8711.8752.271.5171.9711.6352.1011.7032.5933.182.7661.7173.1333.21.9231.81.8221.8681.581.7592.1431.7971.1281.0460.5890.4630.3380.420.3790.4510.2640.189
Operating Income -4.963-3.263-3.043-4.098-4.45429.741-4.245-5.108-4.73-4.403-4.474-3.567-3.145-2.3-1.964-8.034-4.121-3.661-6.013-6.53-8.104-10.902-7.863-8.079-7.545-5.443-4.095-3.535-2.152-1.87-1.872-2.268-1.557-1.969-1.631-2.099-1.708-2.588-3.178-2.738-1.653-3.121-3.091-1.919-1.797-1.637-1.754-1.571-1.749-2.143-1.763-1.043-1.016-0.59-0.463-0.338-0.42-0.379-0.451-0.265-0.189
Operating Income Ratio 00000-929.4060000000-20-24.24700000000000000-1,997.052-671.177-1,024.374-104.434-518.995-308.623-506.224-12.597-102.878-458.314-52.981-9.912-116.905-12.243-309.577-65.16-3.832-7.339-118.557-118.1190-52.327-12.279-34.98100000000
Total Other Income Expenses Net 1.6220.2861.433-0.878-0.396-13.2281.5851.9711.323-3.0480.5654.5480.027-4.724-2.133-4.530.92920.886-5.977-14.903-0.84-2.1984.479-9.5131.902-0.581-0.739-0.0980.0160.0860.092-0.150.1840.3310.3911.322-0.1875.217-0.2363.988-0.25-0.5110.0190.0120.0370.015-0.0110.042-0.002-0.0080.002-0.005-0.0010.001-0.00200.02-0.0030.016-0.021-0
Income Before Tax -3.341-4.055-2.599-3.719-4.312-37.958-4.163-5.084-4.766-4.552-3.7780.981-3.118-5.646-3.22-6.146-4.66617.225-12.04-21.41-8.955-13.1-3.385-17.592-5.642-6.024-4.834-3.633-2.136-1.784-1.78-2.418-1.372-1.639-0.937-0.777-1.8952.629-3.4141.25-1.903-3.632-3.072-1.907-1.76-1.622-1.765-1.529-1.751-2.151-1.761-1.0480-0.589-0.465-0.338-0.4-0.382-0.435-0.2850
Income Before Tax Ratio 000001,186.1880000000-49.096-39.75300000000000000-1,905.278-638.166-1,091.953-92.087-431.867-177.255-187.378-13.977104.514-492.39624.19-11.411-136.032-12.167-307.625-63.802-3.797-7.385-115.389-118.2620-52.262-12.332000000000
Income Tax Expense -0.724-0.889-0.208-0.446-0.289-8.871-0.274-0.155-0.242-0.532-0.736-4.562-0.1663.7591.2183.4020.545-20.936.02214.9350.8873.008-4.3969.472-2.440.538-0.2050.035-0.075-0.08-0.0580.185-0.153-0.328-0.69-1.306-8.126-0.652-0.0330.308-0.229-0.002-0.013-0.003-0.027-0.0040.026-0.0360.0110.00100.013-0.009-0.0010.002-0.004-0.02-0.001-0.0220.012-0
Net Income -2.617-3.166-2.391-3.719-4.023-29.087-3.889-4.929-4.524-4.02-3.7780.981-3.118-5.646-3.22-6.146-4.66617.225-12.04-21.41-8.955-13.1-3.385-17.592-5.642-6.024-4.834-3.633-2.136-1.784-1.78-2.418-1.372-1.639-0.937-0.777-1.8952.629-3.4141.25-1.903-3.632-3.072-1.907-1.76-1.622-1.765-1.529-1.741-2.137-1.761-1.048-1.008-0.589-0.465-0.334-0.4-0.378-0.43-0.277-0.189
Net Income Ratio 00000908.9690000000-49.096-39.75300000000000000-1,905.278-638.166-1,091.953-92.087-431.867-177.255-187.378-13.977104.514-492.39624.19-11.411-136.032-12.167-307.625-63.802-3.797-7.385-115.389-117.5420-52.262-12.332-34.70700000000
EPS -0.24-0.34-0.21-0.49-0.54-3.91-0.52-0.66-0.61-0.54-0.510.18-0.72-1.3-1.54-3.1-2.4710.08-6.66-12.37-5.470-2.29-23.04-8.510-15.23-11.84-6.97-7.99-7.98-10.830-7.38-4.22-3.5011.73-15.434.420-20.77-19.16-12.510-10.7-11.65-10.10-14.71-13.11-7.870-5.75-4.63-3.370-7.03-22.34-14.4-92.92
EPS Diluted -0.24-0.34-0.21-0.49-0.54-3.91-0.52-0.66-0.61-0.54-0.510.18-0.72-1.3-1.54-3.1-2.4710.08-6.66-12.37-5.470-2.29-23.04-8.510-15.23-11.84-6.97-7.99-7.98-10.830-7.38-4.22-3.5011.73-15.434.420-20.77-19.16-12.510-10.7-11.65-10.10-14.71-13.11-7.870-5.75-4.63-3.370-7.03-22.34-14.4-92.92
EBITDA -4.962-3.37-3.042-2.09-3.907-4.156-4.24-5.12-4.563-4.221-4.225-7.084-3.613-5.645-1.964-3.155-3.57340.339-11.475-20.534-8.209-12.9-7.183-7.515-7.493-5.486-4.227-2.986-1.553-1.322-1.367-1.802-1.093-1.517-1.177-1.609-1.557-2.381-2.87-2.388-2.09-2.483-2.594-1.745-1.612-1.457-1.597-1.403-1.542-1.975-1.586-0.863-1.011-0.596-0.487-0.351-0.416-0.377-0.45-0.263-0.188
EBITDA Ratio 00000-929.6560000000-18.435-23.77800000000000000-1,496.346-489.987-793.134-73.366-399.744-222.642-388.027-71.40998.886-377.19540.557-13.906-92.986-10.326-282.027-59.439-3.411-6.572-105.857-103.9540-47.076-10.161-34.82300000000